Your browser doesn't support javascript.
loading
Coronary vascular dysfunction is associated with increased risk of death in patients with peripheral artery disease.
Peri-Okonny, Poghni A; Patel, Krishna K; Garcia, R Angel; Thomas, Merrill; McGhie, A Iain; Bunte, Matthew C; Spertus, John A; Thompson, Randall C; Bateman, Timothy M.
Afiliación
  • Peri-Okonny PA; Department of Cardiology, University of Missouri-Kansas City, Kansas City, MO, USA. apoghni@gmail.com.
  • Patel KK; Department of Cardiology, Saint Luke's Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO, 64111, USA. apoghni@gmail.com.
  • Garcia RA; Department of Medicine (Cardiology) and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Thomas M; Department of Cardiology, University of Missouri-Kansas City, Kansas City, MO, USA.
  • McGhie AI; Department of Cardiology, Saint Luke's Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO, 64111, USA.
  • Bunte MC; Department of Cardiology, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Spertus JA; Department of Cardiology, Saint Luke's Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO, 64111, USA.
  • Thompson RC; Department of Medicine (Cardiology) and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bateman TM; Department of Cardiology, University of Missouri-Kansas City, Kansas City, MO, USA.
J Nucl Cardiol ; 30(6): 2666-2675, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37524997
ABSTRACT

BACKGROUND:

Peripheral artery disease (PAD) and coronary vascular dysfunction are common in patients with cardiometabolic disease. Neither the prevalence of coronary vascular dysfunction among patients with PAD nor the prognostic impact with these two conditions present together has been well studied.

METHODS:

Consecutive patients who underwent PET MPI were analyzed for presence of coronary vascular dysfunction [myocardial blood flow reserve (MBFR) < 2]. Cox regression was used to examine the association of reduced MBFR with mortality in patients with PAD, as well as the association of comorbid MBFR < 2 and PAD with all-cause death.

RESULTS:

Among 13,940 patients, 1936 (14%) had PAD, 7782 (56%) had MBFR < 2 and 1346 (10%) had both PAD and MBFR < 2. Reduced MBFR was very common (69.5%) and was associated with increased risk of all-cause death (HR 1.69, 95%CI 1.32, 2.16, p < 0.01) in patients with PAD. Patients with both PAD and MBFR < 2, and those with either PAD or reduced MBFR had increased risk of death compared to those with neither condition PAD + MBFR < 2 [(HR 95%CI), 2.30; 1.97-2.68], PAD + MBFR ≥ 2 (1.37; (1.08-1.72), PAD - MBFR < 2 (1.98; 1.75-2.25), p < 0.001 for all).

CONCLUSION:

Coronary vascular dysfunction was common in patients with PAD and was associated with increased risk of death.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Enfermedad Arterial Periférica Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Enfermedad Arterial Periférica Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article